Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 28;27(21):7322.
doi: 10.3390/molecules27217322.

Methods of Lysergic Acid Synthesis-The Key Ergot Alkaloid

Affiliations
Review

Methods of Lysergic Acid Synthesis-The Key Ergot Alkaloid

Michał K Jastrzębski et al. Molecules. .

Abstract

Ergot is the spore form of the fungus Claviceps purpurea. Ergot alkaloids are indole compounds that are biosynthetically derived from L-tryptophan and represent the largest group of fungal nitrogen metabolites found in nature. The common part of ergot alkaloids is lysergic acid. This review shows the importance of lysergic acid as a representative of ergot alkaloids. The subject of ergot and its alkaloids is presented, with a particular focus on lysergic acid. All methods of total lysergic acid synthesis-through Woodward, Hendrickson, and Szantay intermediates and Heck coupling methods-are presented. The topic of biosynthesis is also discussed.

Keywords: biosynthesis; ergot alkaloids; lysergic acid; total synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Structure of ergoline.
Figure 2
Figure 2
Structural formulas of the 5 main groups of ergot alkaloids: (a) clavine alkaloids and (b) 6,7-secoergolenes (alkaloids with an open D ring), (c) lysergic acid derivatives, (d) peptide alkaloids, and (e) lactam ergot alkaloids.
Figure 3
Figure 3
Structural formulas of endogenous amines and lysergic acid.
Figure 4
Figure 4
Ergot alkaloid derivatives.
Figure 5
Figure 5
Metergoline.
Figure 6
Figure 6
d-Lysergic acid.
Figure 7
Figure 7
Four stereoisomeric forms of lysergic acid.
Figure 8
Figure 8
Equilibrium between the forms of lysergic acid, explaining the racemization mechanism.
Scheme 1
Scheme 1
Retrosynthetic analysis leading to substrate in the Woodward strategy.
Figure 9
Figure 9
Indole scaffold (red) in the lysergic acid molecule.
Scheme 2
Scheme 2
Obtaining Uhle’s ketone 8.
Figure 10
Figure 10
Structural formulas of amine derivatives (9 and 10).
Scheme 3
Scheme 3
Derivative products strategies implemented.
Scheme 4
Scheme 4
Diol 19 synthesis.
Scheme 5
Scheme 5
Aldehyde 22 synthesis.
Scheme 6
Scheme 6
Ketone 25 synthesis.
Scheme 7
Scheme 7
Reaction of the substitution of bromine 4 with ketal.
Scheme 8
Scheme 8
Woodward pathway to the deprotected key intermediate 2.
Scheme 9
Scheme 9
Woodward pathway to lysergic acid.
Figure 11
Figure 11
Woodward intermediate 31 and deprotected compound 2.
Scheme 10
Scheme 10
Beginning of the synthesis proposed by Baillarge team.
Scheme 11
Scheme 11
Synthesis of the protected Woodward’s intermediate.
Scheme 12
Scheme 12
First part of the Ramage synthesis.
Scheme 13
Scheme 13
Second part of the Ramage synthesis.
Scheme 14
Scheme 14
Obtained epimers of dihydrolysergic acid derivatives 2.
Scheme 15
Scheme 15
Preparation of the Rebek substrate 44.
Scheme 16
Scheme 16
The first part of Rebek synthesis.
Scheme 17
Scheme 17
The second part of Rebek synthesis.
Scheme 18
Scheme 18
The first part of Kiguchi synthesis.
Scheme 19
Scheme 19
The second part of Kiguchi synthesis.
Scheme 20
Scheme 20
The third part of Kiguchi synthesis.
Scheme 21
Scheme 21
The last part of Kiguchi synthesis.
Scheme 22
Scheme 22
Additional Kiguchi research.
Scheme 23
Scheme 23
A new method for the synthesis of compound 51.
Scheme 24
Scheme 24
Coupling reaction leading to a tricyclic system 65.
Scheme 25
Scheme 25
Obtaining Hendickson’s intermediate.
Scheme 26
Scheme 26
Synthesis of lysergic acid ester proposed by Hendrickson.
Scheme 27
Scheme 27
Structural formula of the product obtained in the literature procedure repeated by Bekkam.
Scheme 28
Scheme 28
Coupling reaction leading to a protected tricyclic system 74.
Scheme 29
Scheme 29
Synthetic path leading to the Henrickson’s intermediate, as postulated by Yigang.
Scheme 30
Scheme 30
Beginning of the synthesis proposed by Beaundry.
Scheme 31
Scheme 31
Ending of the synthesis proposed by Beaundry.
Scheme 32
Scheme 32
Beginning of the synthesis proposed by Szantay.
Scheme 33
Scheme 33
Preparation of the carbonyl α,β-unsaturated system 82.
Scheme 34
Scheme 34
Obtaining Szantay’s intermediate.
Scheme 35
Scheme 35
Synthesis of lysergic acid proposed by Szantay.
Figure 12
Figure 12
Structural formulas of compounds obtained in further works of Szantay’s research group.
Scheme 36
Scheme 36
Beginning of the synthesis proposed by Garner.
Scheme 37
Scheme 37
Preparation of a tetracyclic derivative 95 with a camphor substituent.
Scheme 38
Scheme 38
Synthesis of lysergic acid proposed by Garner.
Scheme 39
Scheme 39
Preparation of a tricyclic system by Heck coupling as the source of the D-ring.
Scheme 40
Scheme 40
Synthesis of lysergic acid ester 51 proposed by Ortar.
Scheme 41
Scheme 41
Preparation of a tricyclic system by Kurihara, analogous to that of Ortar.
Scheme 42
Scheme 42
Preparation of a lysergic acid protected ester (R)-31 by the Kurihara strategy.
Scheme 43
Scheme 43
Synthesis of dihydropyridine 112.
Scheme 44
Scheme 44
Protection of the tetrahydropyridine with a nosyl group.
Scheme 45
Scheme 45
Synthesis of tricyclic alcohol 117.
Scheme 46
Scheme 46
Preparation of ester 120.
Scheme 47
Scheme 47
Preparation of lysergic acid in Fukuyama strategy I.
Scheme 48
Scheme 48
Synthesis of cyclic acetate-enamine 124.
Scheme 49
Scheme 49
Introducing an allylic system into molecule 126.
Scheme 50
Scheme 50
Preparation of nitroolefin 129.
Scheme 51
Scheme 51
Forming the B and C rings in Fukuyama strategy II.
Scheme 52
Scheme 52
Preparation of a protected lysergic acid ester 135 by Fukuyama strategy II.
Scheme 53
Scheme 53
Deprotection and methylation of lysergic acid ester 51.
Scheme 54
Scheme 54
Retrosynthetic analysis leading to substrates in Fukuyama strategy III.
Scheme 55
Scheme 55
Preparation of the hemiaminal 136.
Scheme 56
Scheme 56
Preparation of allylamine 142.
Scheme 57
Scheme 57
Reaction of allylamine 142 and the hemiaminal 136, along with reduction by Grubbs catalyst II.
Scheme 58
Scheme 58
Preparation of lysergic acid in Fukuyama strategy III.
Scheme 59
Scheme 59
Beginning of the synthesis according to Fukuyama strategy IV.
Scheme 60
Scheme 60
Preparation of alkyne 154.
Scheme 61
Scheme 61
Synthesis of aziridine 157 in the Mitsunobu reaction.
Scheme 62
Scheme 62
Closing the D-ring in Fukuyama strategy IV.
Scheme 63
Scheme 63
Preparation of lysergic acid in Fukuyama strategy IV.
Scheme 64
Scheme 64
Beginning of the synthesis of lysergic acid from D-glutamic acid 163.
Scheme 65
Scheme 65
Introducing of two terminal double bonds into molecule 166 in strategy I.
Scheme 66
Scheme 66
Method of obtaining lysergic acid proposed by Liu and Jia.
Scheme 67
Scheme 67
Introducing two terminal double bonds into the molecule 173 in strategy II.
Scheme 68
Scheme 68
Synthesis of the ABD tricyclic system in Liu and Jia’s strategy.
Scheme 69
Scheme 69
Preparation of lysergic acid precursor 171.
Scheme 70
Scheme 70
C and D rings closing strategy in the Diels–Alder reaction.
Scheme 71
Scheme 71
Introduction of a masked diene system into the molecule 184.
Scheme 72
Scheme 72
Preparation of lysergic acid by the Oppolzer procedure.
Scheme 73
Scheme 73
Synthesis of thioacetal 190 from bromoindole.
Scheme 74
Scheme 74
Enolate ether 192 synthesis.
Scheme 75
Scheme 75
Obtaining allene in strategy I.
Scheme 76
Scheme 76
Preparation of lysergic acid ester 51 proposed by Inuki, Iwata, and Ohno.
Scheme 77
Scheme 77
Synthesis of materials for the coupling in strategy II.
Scheme 78
Scheme 78
Reaction leads to an asymmetric alcohol 204.
Scheme 79
Scheme 79
Obtaining allene in strategy II.
Scheme 80
Scheme 80
Obtaining intermediate 196 in strategy II.
Scheme 81
Scheme 81
Synthesis of enyne 210 from bromoindole.
Scheme 82
Scheme 82
Obtaining allene in strategy III.
Scheme 83
Scheme 83
Retrosynthetic analysis proposed by Padwa.
Scheme 84
Scheme 84
Beginning of the synthesis proposed by Padwa.
Scheme 85
Scheme 85
Continuation of the synthesis proposed by Padwa.
Scheme 86
Scheme 86
Parsons group synthetic strategies.
Scheme 87
Scheme 87
The first stages of lysergic acid biosynthesis.
Scheme 88
Scheme 88
Biomechanism proposed by Metzger.
Scheme 89
Scheme 89
Enzymatic cyclization of the D-ring.
Scheme 90
Scheme 90
Preparation of lysergic acid from agroclavine.
Scheme 91
Scheme 91
Lysergic acid biosynthesis strategy proposed by Zhu.

Similar articles

Cited by

References

    1. Ochodzki P., National Research Institute . Zapobieganie Zagrożeniom Związanym z Występowaniem w Ziarnie Zbóż Alkaloidów Pasożytniczego Grzyba Buławinki Czerwonej (Sporysz)—Prevention of Risks Associated with the Presence of Alkaloids in the Cereal Grain Parasitic Fungus of Ergot. Expertise; Radzików, Poland: 2015.
    1. Schiff P.L. Ergot and Its Alkaloids. Am. J. Pharm. Educ. 2006;70:98. doi: 10.5688/aj700598. - DOI - PMC - PubMed
    1. Smakosz A., Kurzyna W., Rudko M., Dąsal M. The Usage of Ergot (Claviceps Purpurea (Fr.) Tul.) in Obstetrics and Gynecology: A Historical Perspective. Toxins. 2021;13:492. doi: 10.3390/toxins13070492. - DOI - PMC - PubMed
    1. Krska R., Crews C. Significance, Chemistry and Determination of Ergot Alkaloids: A Review. Food Addit. Contam. Part A. 2008;25:722–731. doi: 10.1080/02652030701765756. - DOI - PubMed
    1. Berde B., Schild H.O., editors. Ergot Alkaloids and Related Compounds. Springer; Berlin/Heidelberg, Germany: 1978.

LinkOut - more resources